Buprenorphine/naloxone

Details

Files

Generic Name:

Buprenorphine/naloxone

Project Status:

Complete

Therapeutic Area:

Opioid drug dependence (Substitution treatment)

Manufacturer:

Schering-Plough Canada Inc

Brand Name:

Suboxone

Project Line:

Reimbursement Review

Project Number:

SR0128-000

Submission Type:

Initial

Indications:

Opioid drug dependence (Substitution treatment)

Recommendation Type:

List with clinical criteria and/or conditions

Final Recommendation:

September 24, 2008

Files

Submission Status Report View PDF

Recommendation and Reasons View PDF

Last Updated : March 6, 2008